Product Information
ABSORICA LD 16 MG CAPSULE is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $38.4106 per EA under NDC 10631000331. Its NADAC has been published 89 times since Jan 22, 2025.
FDA first approved this application on Nov 5, 2019.
The High Outlier badge above means this manufacturer's average price in the isotretinoin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
16 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
10631000331
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
12/17/2025
Active Ingredients
ISOTRETINOINApproval Type
New Drug (NDA)
FDA Application
NDA211913FDA Approved
11/5/2019
On Market Since
11/20/2019
Pharmacological Classes
Price Statistics
The NADAC for ABSORICA LD 16 MG CAPSULE has been published 89 times since Jan 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $38.4106 per EA |
|---|---|
| All-time high | $38.6427 (Nov 12, 2025) |
| All-time low | $38.4106 (Nov 19, 2025) |
| 52-week high | $38.6427 |
| 52-week low | $38.4106 |
| Median price | $38.4106 |
| Average price | $38.5228 |
| Largest weekly change | -0.6% (Nov 19, 2025) |
| Weeks tracked | 89 |
| Tracking since | Jan 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the isotretinoin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
isotretinoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ABSORICA LD 16 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ABSORICA LD 16 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $38.4106 per EA (NDC 10631000331), effective Sep 30, 2026.
How has the price of ABSORICA LD 16 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ABSORICA LD 16 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 89 weekly CMS publications since Jan 22, 2025.
What are the highest and lowest recorded NADAC prices for ABSORICA LD 16 MG CAPSULE?
Since Jan 22, 2025, the NADAC for ABSORICA LD 16 MG CAPSULE has ranged from a low of $38.4106 (Nov 19, 2025) to a high of $38.6427 (Nov 12, 2025), with a median of $38.4106 per EA.
Are there cheaper alternatives to ABSORICA LD 16 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ABSORICA LD 16 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ABSORICA LD 16 MG CAPSULE?
ABSORICA LD 16 MG CAPSULE (NDC 10631000331) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.